Gene Logic Appoints Burrill as Strategic Advisor

Share Article

Gene Logic today announced that it has retained Burrill & Company, Inc. as its strategic advisor. Burrill will assist the company in evaluating strategic alternatives related to Gene Logic and its assets, which could include a sale of its US-based company, operations or its assets. Burrill is actively attempting to identify interested buyers to bid for substantially all of GeneLogic's assets before January 6, 2012.

Ocimum Biosolutions, Inc. (d/b/a Gene Logic) today announced that it has retained Burrill & Company, Inc. as its strategic advisor. Burrill will assist the company in evaluating strategic alternatives related to Gene Logic and its assets, which could include a sale of its US-based company, operations or its assets. Burrill is actively attempting to identify interested buyers to bid for substantially all of GeneLogic's assets before January 6, 2012.

Gene Logic provides a broad range of reliable, high-quality, cost-competitive genomic services in a GLP environment to leading pharmaceutical, biotechnology companies, government and academic institutions. In creating the world’s largest commercial gene expression databases, Gene Logic has developed unparalleled expertise and capabilities in the genomic services industry. Gene Logic maintains a robust physical infrastructure with storage capacity for hundreds of thousands of samples. The company runs multiple gene expression and genotyping platforms and has experience with and standardized procedures for over 200 types of tissue, clinical biopsies, cell lines, and paraffin-embedded samples. The company has multiple levels of bioinformatics analysis to meet varying needs from basic to complex. For clinical trials, Gene Logic provides services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and project management.

Gene Logic has customer relationships with 80% of the 25 largest Pharmaceutical/ Biotech companies and several reputed research and academic institutions. Gene Logic operates a 35,000 Square foot GLP lab in Gaithersburg, MD with close access to FDA and NIH. The company is GLP , HIPAA, HL7 and 21 CFR part 11 compliant. Gene Logic is an innovator in Genomics research with over 65 patents filed, 18 granted.

Ocimum Biosolutions Inc. is a division of Ocimum Biosolutions Ltd., is a global integrated genomic services company which provides comprehensive (research level and clinical GLP-compliant) genomic services, reference databases, and LIMS solutions.

Please contact Stephen Hurly at 415-591-5457 for further information regarding Gene Logic and its assets.

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With more than $1 billion in assets under management, the firm's businesses include venture capital, private equity, merchant banking, and media. By leveraging the scientific and business networks of its investment team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe and Asia.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stephen Hurly
Burrill and Company
415-591-5457
Email >
Visit website